Velkommen til Morningstar Wide Moat nyhedsbrev - uge 7

I denne uges udgave af Morningstar Wide Moat nyhedsbrevet bringer vi et opdateret mix af analyser for danske og svenske selskaber. Vi kigger nærmere på Novo Nordisk, Novozymes, Coloplast, H&M og Nordea som alle holder en moat rating. Blandt de nævnte er Morningstars aktieanalytikeres favoritter Novo Nordisk og Novozymes.   

Facebook Twitter LinkedIn

Læs analysen af Novo Nordisk her.

Læs analysen af Novozymes her.

Læs analysen af Coloplast her. 

Læs analysen af H&M her.

Læs analysen af Nordea her. 

©2014 Morningstar. All rights reserved. The information, data, analyses, and opinions contained herein (1) are proprietary to Morningstar, Inc. and its affiliates (collectively, “Morningstar”), (2) may not be copied or redis­tributed, (3) do not constitute investment advice offered by Morningstar (4) are provided solely for informational purposes and therefore are not an offer to buy or sell a security, and (5) are not warranted to be accurate, complete, or timely. Certain information may be self-reported by the investment vehicle and not subject to independent verification. Morningstar shall not be responsible for any trading decisions, damages, or other losses resulting from, or related to, this information, data, analyses or opinions or their use. Past performance is no guarantee of future results. 

Facebook Twitter LinkedIn

Om forfatteren

Morningstar Equity Analysts  Morningstar stock and fund analysts cover 2,000 mutual funds, 2,100 equities, and 300 exchange-traded funds.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Brugervilkår        Fortrolighedspolitik        Cookie Settings        Offentliggørelser